Sorafenib

• Clinical trial (study) comparing the efficacy and safety of mifamurtide versus standard treatment containing sorafenib in pediatric and youn… Pending
  2026-525223-24-00 Phase II 1 country Instytut Matki I Dziecka
• Paediatric Hepatic International Tumour Trial Recruiting
  2024-516110-38-00 Phase III 10 countries The University Of Birmingham
• Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC): Evaluation of the Optimized Dose, Safety, and Efficacy of Livmoniplimab in Co… Ended
  2022-502948-13-00 Phase II 3 countries Abbvie Deutschland GmbH & Co. KG
• A Study of Atezolizumab with Lenvatinib or Sorafenib versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously … Ended
  2023-503229-21-00 Phase III 12 countries F. Hoffmann-La Roche AG
• Treatment of advanced-stage malignancies harboring BRAF mutations with combination of Sorafenib and Trametinib: a multicenter study Ended
  2024-512887-77-00 Phase I/II 1 country Medical Center - University Of Freiburg
• Study to evaluate the safety and efficacy of nivolumab combined with ipilimumab as first-line (1L) therapy for participants with advanced HC… Ended
  2023-508635-31-00 Phase III 8 countries Bristol-Myers Squibb Services Unlimited Company
• A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184) in Combination with Atezolizumab versus Sorafenib in Subjects with Advanced H… Ended
  2024-516479-34-00 Phase III 5 countries Exelixis Inc.
• This is a randomized, open-label, multi-center, global, Phase III study to assess the effectiveness and safety of two Immune Therapy drugs, … Ended
  2024-512212-21-00 Phase III 4 countries AstraZeneca AB
• Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized … Ended
  2023-509092-16-00 Phase II 1 country Akershus University Hospital

Showing 1–9 of 9 trials